Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice

Veterinary Immunology and Immunopathology

Volumn 70, Issue 1-2, 1999, Pages 67-83

  Hölscher, Christoph ^a   Hasch, Georg ^a   Joswig, Norbert ^a   Stauffer, Uta ^a   Müller, Uwe ^a   Mossmann, Horst ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

Adoptive Transfer; Cattle; Lymphocytes; Mice; SCID

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CATTLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; B-LYMPHOCYTES; CATTLE; FLOW CYTOMETRY; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MICE; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 17944403112     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(99)00065-3     Document Type: Article

References (54)

1. Aaberge I.S., Michaelsen T.E., Rolstad A.K., Groeng E.C., Solberg P., Lovik M. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect. Immun. 60:1992;4146-4153.
2. Armstrong N., Cigel F., Borcherding W., Hong R., Malkovska V. In vitro preactivated human T cells engraft in SCID mice and migrate to murine lymphoid tissues. Clin. Exp. Immunol. 90:1992;476-482.
3. Bellamy W.T., Odeleye A., Finley P., Huizenga B., Dalton W.S., Weinstein R.S., Hersh E.M., Grogan T.M. An in vivo model of human multidrug-resistant multiple myeloma in SCID mice. Am. J. Pathol. 142:1993;691-698.
4. Boermans H.J., Percy D.H., Stirtzinger T., Croy B.A. Engraftment of severe combined immune deficient/beige mice with bovine foetal lymphoid tissues. Vet. Immunol. Immunopathol. 34:1992;273-289.
5. Bonyhadi M.L., Kaneshima H. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. Mol. Med. Today. 3:1997;246-253.
6. Bosma G.C., Custer R.P., Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature. 301:1983;527-530.
7. Cannon M.J., Pisa P., Fox R.I., Cooper N.R. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J. Clin. Invest. 85:1990;1333-1337.
8. Cesano A., O'Connor R., Nowell P.C., Lange B., Clark S.C., Santoli D. Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice. Blood. 81:1993;2714-2722.
9. Denny S.L., Brackett N.Y., Mann F.A., Kreeger J.M., Estes D.M. Antigen-specific humoral immune responses to a hapten-carrier conjugate in SCID mice engrafted with bovine fetal hematopoietic tissues. Lab. Anim. Sci. 46:1996;48-55.
10. Dorshkind K., Keller G.M., Phillips R.A., Miller R.G., Bosma G.C., O'Toole M., Bosma M.J. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J. Immunol. 132:1984;1804-1808.
11. Duchosal M.A., Eming S.A., McConahey P.J., Dixon F.J. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease. Am. J. Pathol. 141:1992;1097-1113.
12. Fuzzati-Armentero M.T., Duchosal M.A. hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease. Histol. Histopathol. 13:1998;155-168.
13. Garnier J.L., Cannon M.J., Chargui J., Touraine J.L., Cooper N.R. EBV human B-cell lymphomas in Scid mice: description of the model and study of the role of anti-CD40 and anti-CD23 monoclonal antibodies in their development. Transplant. Proc. 25:1993;1387-1388.
14. Garnier J.L., Cooper N.R., Cannon M.J. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice. Am. J. Pathol. 142:1993;353-358.
15. Greenwood J.D., Bos N.A., Croy B.A. Offspring of xenogeneically-reconstituted scid/scid mice are capable of a primary xenogeneic immune response to DNP-KLH. Vet. Immunol. Immunopathol. 50:1996;145-155.
16. Greenwood J.D., Croy B.A. A study on the engraftment and trafficking of bovine peripheral blood leukocytes in severe combined immunodeficient mice. Vet. Immunol. Immunopathol. 38:1993;21-44.
17. Greenwood J.D., Croy B.A., Trout D.R., Wilcock B.P. Xenogeneic (bovine) peripheral blood leukocytes engrafted into severe combined immunodeficient mice retain primary immune function. Vet. Immunol. Immunopathol. 59:1997;93-112.
18. Greiner D.L., Hesselton R.A., Shultz L.D. SCID mouse models of human stem cell engraftment. Stem Cells. 16:1998;166-177.
19. Haas L., Perdrizet J., Butt M., Posso M., Quimby F., Casey J.W. Engraftment of bovine leukemia virus infected lymphocytes into SCID mice. Virology. 192:1993;655-658.
20. Herz U., Schnoy N., Borelli S., Weigl L., Kasbohrer U., Daser A., Wahn U., Kottgen E., Renz H. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production. J. Invest. Dermatol. 110:1998;224-231.
21. Howard C.J., Naessens J. Summary of workshop findings for cattle (Tables 1 and 2). Vet. Immunol. Immunopathol. 39:1993;1-3.
22. Huang Y.W., Richardson J.A., Tong A.W., Zhang B.Q., Stone M.J., Vitetta E.S. Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res. 53:1993;1392-1396.
23. Jansen B., Kersey J.H., Jaszcz W.B., Gunther R., Nguyen D.P., Chelstrom L.M., Tuel-Ahlgren L., Uckun F.M. Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide. Leukemia. 7:1993;290-297.
24. Kamel-Reid S., Dick J.E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science. 242:1988;1706-1709.
25. Kamel-Reid S., Letarte M., Sirard C., Doedens M., Grunberger T., Fulop G., Freedman M.H., Phillips R.A., Dick J.E. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science. 246:1989;1597-1600.
26. Kilchherr E., Mandak V., Wagner K., Heusser C.H. Regulation of human IgE response in hu-PBL-SCID mice. Cell. Immunol. 151:1993;241-256.
27. Kirchgessner C.U., Patil C.K., Evans J.W., Cuomo C.A., Fried L.M., Carter T., Oettinger M.A., Brown J.M. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science. 267:1995;1178-1183.
28. Krams S.M., Dorshkind K., Gershwin M.E. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J. Exp. Med. 170:1989;1919-1930.
29. Lapidot T., Fajerman Y., Kollet O. Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis. J. Mol. Med. 75:1997;664-673.
30. Lapidot T., Pflumio F., Doedens M., Murdoch B., Williams D.E., Dick J.E. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science. 255:1992;1137-1141.
31. Lubin I., Faktorowich Y., Lapidot T., Gan Y., Eshhar Z., Gazit E., Levite M., Reisner Y. Engraftment and development of human T and B cells in mice after bone marrow transplantation. Science. 252:1991;427-431.
32. Mazingue C., Cottrez F., Auriault C., Cesbron J.Y., Capron A. Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells. Eur. J. Immunol. 21:1991;1763-1766.
33. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 241:1988;1632-1639.
34. Mocarski E.S., Bonyhadi M., Salimi S., McCune J.M., Kaneshima H. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc. Natl. Acad. Sci. USA. 90:1993;104-108.
35. Mosier D.E., Gulizia R.J., Baird S.M., Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 335:1988;256-259.
36. Mosier D.E., Gulizia R.J., MacIsaac P.D., Corey L., Greenberg P.D. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc. Natl. Acad. Sci. USA. 90:1993;2443-2447.
37. Mossmann, H., Nicklas, W., Hedrich, H., 1998. Manangement of immunocompromised and infected animals. In: Kaufmann, S., Kabelitz, D. (Eds.), Methods in Microbiology, vol. 25. Academic Press, San Diego, pp. 109-188.
38. Mutwiri G.K., Butler D.G., Rosendal S., Yager J. Experimental infection of severe combined immunodeficient beige mice with Mycobacterium paratuberculosis of bovine origin. Infect. Immunol. 60:1992;4074-4079.
39. Nakamine H., Masih A.S., Okano M., Taguchi Y., Pirruccello S.J., Davis J.R., Mahloch M.L., Beisel K.W., Kleveland K., Sanger W.G. Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency. Am. J. Pathol. 142:1933;139-147.
40. Nguyen H., Sandhu J., Hozumi N. Production of human monoclonal antibodies in SCID mouse. Microbiol. Immunol. 41:1997;901-907.
41. Picchio G.R., Kobayashi R., Kirven M., Baird S.M., Kipps T.J., Mosier D.E. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. Cancer Res. 52:1992;2468-2477.
42. + T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice. Eur. J. Immunol. 21:1991;1591-1600.
43. Safrit J.T., Fung M.S., Andrews C.A., Braun D.G., Sun W.N., Chang T.W., Koup R.A. Hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. Aids. 7:1993;15-21.
44. Saxon A., Macy E., Denis K., Tary-Lehmann M., Witte O., Braun J. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J. Clin. Invest. 87:1991;658-665.
45. Schuler W., Weiler I.J., Schuler A., Phillips R.A., Rosenberg N., Mak T.W., Kearney J.F., Perry R.P., Bosma M.J. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell. 46:1986;963-972.
46. Shah S.A., Halloran P.M., Ferris C.A., Levine B.A., Bourret L.A., Goldmacher V.S., Blattler W.A. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models. Cancer Res. 53:1993;1360-1367.
47. Simpson E., Farrant J., Chandler P. Phenotypic and functional studies of human peripheral blood lymphocytes engrafted in scid mice. Immunol. Rev. 124:1991;97-111.
48. Steinsvik T.E., Gaarder P.I., Aaberge I.S., Lovik Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes. Scand. J. Immunol. 42:1995;607-616.
49. Tary-Lehmann M., Saxon A. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med. 175:1992;503-516.
50. Torbett B.E., Picchio G., Mosier D.E. Hu-PBL-SCID mice: a model for human immune function AIDS, and lymphomagenesis. Immunol. Rev. 124:1991;139-164.
51. Tsuji M., Hagiwara K., Takahashi K., Ishihara C., Azuma I., Siddiqui W.A. Theileria sergenti proliferates in SCID mice with bovine erythrocyte transfusion. J. Parasitol. 78:1992;750-752.
52. Vandekerckhove B.A., Baccala R., Jones D., Kono D.H., Theofilopoulos A.N., Roncarolo M.G. Thymic selection of the human T cell receptor V beta repertoire in SCID-hu mice. J. Exp. Med. 176:1992;1619-1624.
53. Vandekerckhove B.A., Jones D., Punnonen J., Schols D., Lin H.C., Duncan B., Bacchetta R., de Vries J.E., Roncarolo M.G. Human Ig production and isotype switching in severe combined immunodeficient-human mice. J. Immunol. 151:1993;128-137.
54. Williams S.S., Umemoto T., Kida H., Repasky E.A., Bankert R.B. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies. J. Immunol. 149:1992;2830-2836.